Table 1.
Biological Functions of GDM-Related Circulating miRNAs
Study | Groups/Number | Stage of Pregnancy (weeks) | miRNA | Target Pathway | Species | Source | Role/Biological Function |
---|---|---|---|---|---|---|---|
Xuegui Zhou16 | 108 GDM | 24–28 | miR-132 | HTR-8/SVneo cells | Human | Serum and placenta | Promote the trophoblast cell proliferation |
50 CTRL | |||||||
Chun Zhao17 | 32 GDM | 16–19 | miR-132, miR-29a and miR-222 | PCK2 in HepG2 cell lines. | Human | Serum | Decrease Insulin-induced gene 1 (Insig1) |
32 CTRL | |||||||
Carmen Pheiffer18 | 81 | 13–31 | miR-20a-5p, miR-222-3p | – | Human | Serum | Various metabolic pathways, including insulin signaling. |
Shuping Qi19 | 156 | 24–28 | miR-185 | – | Human | Serum and placental | Increase FPG, FINS, and HOMA-IR |
Chun-Yi Guan20 | 137GDM | 24–28 | miR-21-5p | PPAR-α | Human | Serum | Inhibits cell growth and infiltration, affect the placental function. |
158CTRL | |||||||
Li Deng21 | 68GDM | 24–28 | miR-29a/b | – | Human | Serum | Neonatal pathologic jaundice |
55CTRL | |||||||
Songbo Fu22 | 90 GDM | – | miR-875-5p | TXNRD1 | Rat | Serum | Reduced FBG and insulin resistance, reduced expression levels of blood lipid and pro-inflammatory markers as well as reduced oxidative stress |
10CTRL | |||||||
Guido Sebastiani23 | 21 GDM | 24–33 | miR-330-3p | Directly be transferred from plasma to beta-cells | Human | Plasma | Modulating key target genes involved in proliferation, differentiation, and insulin secretion. |
10 CTRL | |||||||
Jianping Wang24 | 102 GDM | 24–28 | miR-195-5p | – | Human | Serum | Fasting plasma glucose, one‐hour plasma glucose, two‐hour plasma glucose, and BMI |
102 CRTL | |||||||
Sujuan Dai25 | 67GDM | 24–28 | miR-2467 | Adiponectin | Human | Serum | Increase (BMI), TC, TG, LDL-C, FPG, HbA1c, HOMA-IR |
60CTRL | |||||||
Anja Elaine Sørensen26 | 82GDM | <20,24–28,35-37 | miR-16-5p, −29a-3p, and −134-5p | – | Human | Serum | Increase the incident of macrosomia |
41CRTL | |||||||
Lijun Liu27 | 110 GDM | 24–28 | miR-1323 | TP53INP1 | Human | Blood | Promote the trophoblast cell viability under HG conditions |
78CTRL | |||||||
Hui Shen28 | 25GDM | 20–24 | miR-181d | IRS-2 | Human | Serum | Modulated the process of insulin signaling and cell viability and apoptosis in pancreatic β cells |
30CTRL | |||||||
Jie Wen29 | 32 GDM | 25–31 | miR-520h | mTOR | Human | Serum | Inhibit cell viability and promote cell apoptosis |
48CTRL | |||||||
Fuyan Wang30 | 53GDM | 24–28 | miR-574-5p and miR-3135b | The metabolism of glucose and lipids, the insulin signaling pathway | Human | Plasma | Levels of blood glucose and LDL-C; HDL-C |
46CTRL | |||||||
Tao Zheng31 | 60 | – | miR-23a-3p | NOV | Rat | Blood and adipocytes | Increase bodyweight, glucose level, insulin level |
Alejandra Martínez-Ibarra32 | 18GDM | 28–40 | miR-9-5p, miR-16-5p, miR-29a-3p and miR-330-3p | - | Human | Sera | Urinary MEHP and BPA increase |
22CTRL | |||||||
H-X Li33 | 60 | – | miR-26b | PI3K/AKT | Rat | Serum | Trophoblast dysfunction |
Abbreviations: CTRL, control; GDM, gestational diabetes mellitus; TXNRD1, thioredoxin reductase 1; PCK2, phosphoenolpyruvate carboxy kinase2; TP53INP1, tumor protein p53 inducible nuclear protein 1; miRNA, microRNA; PPARα, peroxisome proliferator-activated receptor α.